Company Profile
Medannex Limited
sc363190•Private Limited With Share Capital
Get Full Access
28/07/2009
16 years
6
12
72110
moderate risk
Company Overview
Registration, classification & business activity
Medannex Limited (sc363190) is a private limited with share capital incorporated on 28/07/2009 (16 years old) and registered in edinburgh, EH39QA. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Medannex is an award-winning scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-a1. our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. following a recent series b fundraise, ...
Financial Overview
£1.57M
£877.9K
£691.2K
£231.7K
Key Metrics
12
Employees
6
Directors
88
Shareholders
6
Patents
Board of Directors
Innovate Grants
This company received a grant of £203129.0 for A Novel Treatment For Systemic Lupus Erythematosus. The project started on 01/01/2019 and ended on 31/07/2020.
This company received a grant of £106608.6 for Proof Of Concept Evaluation For A Novel Colorectal Cancer Therapeutic. The project started on 01/12/2019 and ended on 28/02/2021.
+1 more grants available
Risk Assessment
moderate risk
International Score
Future Factor
good
Performance Rating